
1. j infect dis. 2006 mar 15;193(6):760-4. epub 2006 feb 13.

recovery drug-resistant influenza virus immunocompromised patients: a
case series.

ison mg(1), gubareva lv, atmar rl, treanor j, hayden fg.

author information: 
(1)division infectious diseases international health, department of
medicine, university virginia health sciences center, charlottesville, 22908, 
usa.

comment in
    j infect dis. 2006 mar 15;193(6):751-3.

influenza virus resistance antiviral drugs emerges increased
frequency immunocompromised patients limit benefit m2 and
neuraminidase (na) inhibitors. document 3 cases influenza severely
immunocompromised patients virus variants molecular markers of
resistance anti-influenza drugs recovered. virus variants recovered 
2 patients mutations m2, na (with previously recognized glu119val na
substitution), hemagglutinin genes. describe novel asp198asn na mutation
in influenza b virus decreased susceptibility oseltamivir 
zanamivir.

doi: 10.1086/500465 
pmid: 16479508  [indexed medline]

